On Monday, November 16, 2020, the Company, Corbus Pharmaceuticals Holdings, Inc., CRBP stock construct a change of -4.69 percent (Loss) in a total of its share price and having its trading value $1.22, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $110.57M with the total Outstanding Shares of 81.88M.
P/S, P/E, P/B & P/C values of (NASDAQ: CRBP):
Corbus Pharmaceuticals Holdings, Inc. institutional ownership is standing at 74.3 percent, while insider ownership is 1.73 percent. As of now, CRBP has a P/S, P/E and, P/B values of 18.74, 0, and 3.39 respectively. Its P/Cash is valued at 1.35.
The stock SMA50 is now at -22.55 percent. In looking, the SMA 200 we see that the stock has seen a -77.01 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Profitability ratios:
Looking into the profitability ratios of CRBP stock, an investor will find its ROE, ROA, ROI standing at -485.5 percent, -167.7 percent and, 0 percent, respectively.
Beta Factor:
A beta factor is used to measure the volatility of the stock. The stock remaining at 14.44 percent volatile for the week and 10.23 percent for the month.
Gross / Operating Margins of CRBP:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price:
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Corbus Pharmaceuticals Holdings, Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of Corbus Pharmaceuticals Holdings, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 0 percent, resulting in a performance for the month at 9.91 percent.
Therefore, the stated figure displays a quarterly performance of -83.72 percent, bringing six-month performance to -82.79 percent and year to date performance of -77.66 percent. As of now, Corbus Pharmaceuticals Holdings, Inc. has a P/S, P/E and, P/B values of 18.74, 0, and 3.39 respectively. Its P/Cash is valued at 1.35.
Earnings per Share Details of Corbus Pharmaceuticals Holdings, Inc.:
The EPS of CRBP is strolling at -1.78, measuring its EPS growth this year at -14.5 percent. As a result, the company has an EPS growth of 54 percent for the approaching year.
